We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current MMIRF market cap is 39.22M. The company's latest EPS is CAD -0.0046 and P/E is -15.22.
| Year End 31 July 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 919k | 2.14M | 952k | 432k | 412k |
| Operating Income | -1.3M | -184k | -1.45M | -1.95M | -2.57M |
| Net Income | -2.05M | -676k | -1.83M | -2.68M | -3.33M |
| Year End 31 July 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 3.4M | 3.89M | 3.83M | 3.65M | 6.07M |
| Total Liabilities | 18.96M | 19.61M | 16.19M | 18.68M | 24.11M |
| Total Equity | -15.56M | -15.72M | -12.36M | -15.03M | -18.04M |
| Year End 31 July 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -315k | -505k | -1.88M | -1.27M | -2.94M |
| Investing | -102k | -37k | -70k | -1,000 | -742k |
| Financing | 731k | 140k | 1.99M | 1.25M | 5.77M |
| Market Cap | 39.22M |
| Price to Earnings Ratio | -15.22 |
| Price to Sales Ratio | 116.67 |
| Price to Cash Ratio | 24.14 |
| Price to Book Ratio | -2.79 |
| Dividend Yield | - |
| Shares Outstanding | 718.31M |
| Average Volume (1 week) | 73.75k |
| Average Volume (1 Month) | 33.92k |
| 52 Week Change | 26.98% |
| 52 Week High | 0.20 |
| 52 Week Low | 0.013 |
| Spread (Intraday) | 1.19 (98.91%) |
| Company Name | Medmira Inc (PK) |
| Address |
155 chain lake drive halifax, nova scotia B3S 1B3 |
| Website | https://www.medmira.com |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
